This topic contains a solution. Click here to go to the answer

Author Question: In an unregulated market for healthcare, there is A) a deadweight loss from over-providing ... (Read 104 times)

AEWBW

  • Hero Member
  • *****
  • Posts: 579
In an unregulated market for healthcare, there is
 
  A) a deadweight loss from over-providing healthcare.
  B) a deadweight loss from under-providing healthcare.
  C) no deadweight loss.
  D) Any of the above could be correcting depending on how the marginal cost paid by producers compares to the marginal social cost.

Question 2

A tax equal to the external marginal cost of an activity yields the efficient level of production because the tax
 
  A) achieves the competitive equilibrium.
  B) forces producers to face all costs of production including the external cost.
  C) ensures greater profits for the firm.
  D) eliminates all pollution.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

shaikhs

  • Sr. Member
  • ****
  • Posts: 312
Answer to Question 1

B

Answer to Question 2

B




shaikhs

  • Sr. Member
  • ****
  • Posts: 312

 

Did you know?

Glaucoma is a leading cause of blindness. As of yet, there is no cure. Everyone is at risk, and there may be no warning signs. It is six to eight times more common in African Americans than in whites. The best and most effective way to detect glaucoma is to receive a dilated eye examination.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

About 600,000 particles of skin are shed every hour by each human. If you live to age 70 years, you have shed 105 pounds of dead skin.

Did you know?

Approximately one in four people diagnosed with diabetes will develop foot problems. Of these, about one-third will require lower extremity amputation.

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

For a complete list of videos, visit our video library